Amy Coward

Virulence genes in isolates of Klebsiella pneumoniae from the UK during 2016, including among carbapenemase gene-positive hypervirulent K1-ST23 and ‘non-hypervirulent’ types ST147, ST15 and ST383

Jane F. Turton, Zoë Payne, Amy Coward et al. · Journal of Medical Microbiology · 2017 · 133 citations

Life Sciences, Infectious Diseases, Microbiology +17

Prevalence of Burkholderia species, including members of Burkholderia cepacia complex, among UK cystic and non-cystic fibrosis patients

D. Kenna, Daniel Lilley, Amy Coward et al. · Journal of Medical Microbiology · 2017 · 95 citations

Life Sciences, Infectious Diseases, Microbiology +17

Use of nrdA gene sequence clustering to estimate the prevalence of different Achromobacter species among Cystic Fibrosis patients in the UK

Amy Coward, D. Kenna, Claire Perry et al. · Journal of Cystic Fibrosis · 2015 · 50 citations

Life Sciences, Microbiology, Molecular Biology +12

CoV2-ID, a MIQE-compliant sub-20-min 5-plex RT-PCR assay targeting SARS-CoV-2 for the diagnosis of COVID-19

Stephen A. Bustin, Amy Coward, Garry Sadler et al. · Scientific Reports · 2020 · 31 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Structured surveillance of Achromobacter, Pandoraea and Ralstonia species from patients in England with cystic fibrosis

Amy Coward, D. Kenna, Neil Woodford et al. · Journal of Cystic Fibrosis · 2019 · 21 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16